Naghavi v. Belter Health Measurement and Analysis Technology Co., Ltd.

CourtDistrict Court, S.D. California
DecidedOctober 20, 2020
Docket3:20-cv-01723
StatusUnknown

This text of Naghavi v. Belter Health Measurement and Analysis Technology Co., Ltd. (Naghavi v. Belter Health Measurement and Analysis Technology Co., Ltd.) is published on Counsel Stack Legal Research, covering District Court, S.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Naghavi v. Belter Health Measurement and Analysis Technology Co., Ltd., (S.D. Cal. 2020).

Opinion

1 2 3 4 5 6 UNITED STATES DISTRICT COURT 7 SOUTHERN DISTRICT OF CALIFORNIA 8 9 DR. MORTEZA NAGHAVI, M.D., an Case No.: 20-cv-01723-H-KSC individual; MEDITEX CAPITAL, LLC, a 10 Delaware limited liability company; and ORDER: 11 AMERICAN HEART TECHNOLOGIES, LLC, a Delaware limited liability (1) GRANTING IN PART AND 12 company, DENYING IN PART DEFENDANT 13 BELTER’S MOTION TO DISMISS; Plaintiffs, AND 14 v. 15 [Doc. No. 3.] BELTER HEALTH MEASUREMENT

16 AND ANALYSIS TECHNOLOGY CO., (2) GRANTING DEFENDANT LTD., a China corporation; EASTONE 17 EASTONE’S MOTION TO DISMISS CENTURY TECHNOLOGY CO. LTD., a

18 China corporation; XIBIN XU, an [Doc. No. 6.] individual; WEI WANG, an individual; 19 WENWEI TONG, an individual; 20 FEIPENG ZHONG, an individual; ZHUHAI HENGQIN XUANYUAN NO. 21 8 EQUITY INVESTMENT 22 PARTNERSHIP (LIMITED PARTNERSHIP), a China limited 23 partnership; GF SECURITIES, a China 24 corporation; and DOES 1 through 20, inclusive, 25 Defendants. 26

27 /// 28 1 On September 9, 2020, Defendant Belter Health Measurement and Analysis 2 Technology Co., Ltd. filed a motion to dismiss Plaintiffs Dr. Morteza Naghavi, M.D., 3 Meditex Capital, LLC, and American Heart Technologies, LLC’s first amended complaint 4 pursuant to Federal Rule of Civil Procedure 12(b)(6) for failure to state a claim. (Doc. No. 5 3.) On September 21, 2020, Defendant Eastone Century Technology Co., Ltd. filed a 6 motion to dismiss Plaintiffs’ FAC pursuant to Rule 12(b)(2) for lack of personal 7 jurisdiction and pursuant to Rule 12(b)(1) for failure to state a claim. (Doc. No. 6.) On 8 October 5, 2020, Plaintiffs filed their responses in opposition to Defendants Belter and 9 Eastone’s motions to dismiss. (Doc. Nos. 7, 8.) On October 9, 2020, Defendants Belter 10 and Eastone filed their replies. (Doc. Nos. 11, 12.) On October 13, 2020, the Court took 11 the motions under submission.1 (Doc. No. 13.) For the reasons below, the Court grants in 12 part and denies in part Defendant Belter’s motion to dismiss, and the Court grants 13 Defendant Eastone’s motion to dismiss. 14 BACKGROUND 15 The following facts are taken from the allegations in Plaintiffs’ first amended 16 complaint. Plaintiffs Meditex Capital, LLC and American Heart Technologies, LLC are 17 Delaware limited liability companies and are partners in a joint venture to manufacture, 18 market, and distribute cardiovascular devices, including a cardiovascular device called 19 “VENDYS.” (Doc. No. 1-13, FAC ¶¶ 1-2, 18.) Plaintiff Dr. Morteza Neghavi is the 20 founder and managing member of Meditex and American Heart. (Id. ¶¶ 3, 18.) 21 Defendant Belter Health Measurement and Analysis Technology Co., Ltd. is a 22 manufacturer and distributor of medical devices in China. (Id. ¶¶ 4, 21.) Defendant 23 24 25 26 1 In the Court’s October 13, 2020, order taking the matter under submission, the Court ordered Plaintiffs to file a revised version of Exhibit G to their FAC because the current version of Exhibit G 27 appeared to be missing a page. (Doc. No. 13.) On October 15, 2020, Plaintiffs filed a revised version of 28 Exhibit G correcting the error. (Doc. No. 15.) 1 Eastone Century Technology Co., Ltd. is a publicly traded China corporation and was the 2 100% owner of Belter until on or about January 2020.2 (Id. ¶ 5.) 3 On March 18, 2016, Belter and Meditex entered into a “Manufacturing, Marketing, 4 Sales and Distribution Agreement” (“the March 18, 2016 agreement”) wherein Meditex 5 granted Belter exclusive rights to market, distribute, and sell VENDYS in China. (Doc. 6 No. 1-13, FAC ¶ 21, Ex. B at 1, 2 § 2.4.) On February 10, 2017, Belter and Meditex entered 7 into an amendment to the March 18, 2016 agreement (“the February 10, 2017 agreement”). 8 (Id. ¶ 23, Ex. D.) 9 On May 2, 2017, Belter and Meditex entered into another agreement entitled the 10 “Exclusive China Marketing, Sales, and Distribution Agreement” (“the May 2, 2017 11 agreement”). (Id. ¶ 24; Doc. No. 14 Ex. G.) The May 2, 2017 agreement provides: “This 12 contract substitutes all terms related to MARKETING, SALES, and DISTRIBUTION 13 AGREEMENT previously signed by the parties on March 18th, 2016.” (Doc. No. 14, Ex. 14 G at 1.) Plaintiffs allege that the May 2, 2017 agreement contains certain minimum sales 15 requirements, and that Defendant Belter has failed to meet those minimum sales 16 requirements. (Doc. No. 1-13, FAC ¶¶ 24, 36; see Doc. No. 14, Ex. G at 3 § 5, Ex. B.) 17 On August 10, 2018, Belter and Meditex entered into an additional amendment 18 agreement (“the August 10, 2018 amendment”). (Doc. No. 1-13, FAC ¶ 32, Ex. K.) 19 Plaintiffs allege that under the terms of the August 10, 2018 amendment, Belter was 20 required to pay Meditex $250,000 for an outstanding licensing fee, and Belter was required 21 to provide additional VENDYS units to Plaintiffs in the United States. (Id. ¶ 32.) Plaintiffs 22 allege that although Defendants Belter and Eastone have paid $100,000 of the outstanding 23 $250,000, they have failed to pay the remaining $150,000 of the licensing fee and have not 24 delivered the required VENDYS units. (Id. ¶ 33.) 25 26 27 28 2 On or about January 2020, Eastone sold its ownership interest in Belter to Zhuhai Hengqin 1 On November 26, 2019, Plaintiffs Dr. Naghavi, Meditex, and American Heart 2 Technologies filed a complaint in the Superior Court of California, County of San Diego. 3 (Doc. No. 1, Notice of Removal ¶ 1.) On February 7, 2020, Plaintiffs filed a first amended 4 complaint in state court against Defendants Belter, Eastone, Xibin Xu, Wei Wang, Wenwei 5 Tong, Feipeng Zhong, Zhuhai Hengqin Xuanyuan, and GF Securities. (Doc. No. 1-13, 6 FAC.) In the FAC, Plaintiffs allege claims for: (1) breach of contract; (2) breach of the 7 implied covenant of good faith and fair dealing; (3) fraud by false promise; (4) to set aside 8 a voidable transaction; and (5) conspiracy. (Id. ¶¶ 34-72.) 9 On September 2, 2020, Defendants Belter and Eastone removed the action from state 10 court to the United States District Court for the Southern District of California pursuant to 11 28 U.S.C. § 1441 on the basis of diversity jurisdiction under 28 U.S.C. § 1332. (Doc. No. 12 1, Notice of Removal.) On October 6, 2020, the Court granted Defendant GF Securities’s 13 motion to dismiss, and the Court dismissed Defendant GF Securities from the action. (Doc. 14 No. 10.) By the present motions: (1) Defendant Eastone moves pursuant to Federal Rule 15 of Civil Procedure 12(b)(2) to dismiss Plaintiffs’ complaint for lack of personal 16 jurisdiction; and (2) Defendants Belter and Eastone both move pursuant to Federal Rule of 17 Civil Procedure 12(b)(6) to dismiss Plaintiffs’ complaint for failure to state a claim. (Doc. 18 No. 3-1, 6-1.) 19 DISCUSSION 20 I. Legal Standards for a Rule 12(b)(6) Motion to Dismiss 21 A motion to dismiss under Federal Rule of Civil Procedure 12(b)(6) tests the legal 22 sufficiency of the pleadings and allows a court to dismiss a complaint if the plaintiff has 23 failed to state a claim upon which relief can be granted. See Conservation Force v. Salazar, 24 646 F.3d 1240, 1241 (9th Cir. 2011). Federal Rule of Civil Procedure

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bayley v. Greenleaf
20 U.S. 46 (Supreme Court, 1822)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
TELESAURUS VPC, LLC v. Power
623 F.3d 998 (Ninth Circuit, 2010)
Conservation Force v. Salazar
646 F.3d 1240 (Ninth Circuit, 2011)
Mendiondo v. Centinela Hospital Medical Center
521 F.3d 1097 (Ninth Circuit, 2008)
Coto Settlement v. Eisenberg
593 F.3d 1031 (Ninth Circuit, 2010)
McLaughlin, Inc. v. Northstar Drilling Technologies, Inc.
138 S.W.3d 24 (Court of Appeals of Texas, 2004)
Ernst & Young, L.L.P. v. Pacific Mutual Life Insurance Co.
51 S.W.3d 573 (Texas Supreme Court, 2001)
Criswell v. European Crossroads Shopping Center, Ltd.
792 S.W.2d 945 (Texas Supreme Court, 1990)
Monaco v. Bear Stearns Residential Mortgage Corp.
554 F. Supp. 2d 1034 (C.D. California, 2008)
Northrup v. Southwestern Bell Telephone Co.
72 S.W.3d 1 (Court of Appeals of Texas, 2001)
Tarmann v. State Farm Mutual Automobile Insurance
2 Cal. App. 4th 153 (California Court of Appeal, 1991)
Solar Applications Engineering, Inc. v. T.A. Operating Corp.
327 S.W.3d 104 (Texas Supreme Court, 2010)
Airborne Freight Corp. v. C.R. Lee Enterprises, Inc.
847 S.W.2d 289 (Court of Appeals of Texas, 1993)
Garcia v. Vera
342 S.W.3d 721 (Court of Appeals of Texas, 2011)
Cajun Constructors, Inc. v. Velasco Drainage District
380 S.W.3d 819 (Court of Appeals of Texas, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
Naghavi v. Belter Health Measurement and Analysis Technology Co., Ltd., Counsel Stack Legal Research, https://law.counselstack.com/opinion/naghavi-v-belter-health-measurement-and-analysis-technology-co-ltd-casd-2020.